The other effect of intravenously administered respiratory syncytial virus-enriched immune globulin for prophylaxis: less acute otitis media.
Harrison
C J
CJ
D000208:Acute Disease; D006192:Haemophilus Infections / Q000517:prevention & control; D006193:Haemophilus influenzae; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D007223:Infant; D010033:Otitis Media / Q000175:diagnosis / Q000191:economics / Q000382:microbiology / Q000517:prevention & control*; D011008:Pneumococcal Infections / Q000517:prevention & control; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses / Q000276:immunology*
D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous